Welcome to CoffyLaw
Whether you’re protecting your right to benefit from something you’ve created or are looking to provide your loved ones the best chance at a successful future, skilled legal counsel gives you an advantage. At CoffyLaw, LLC, our boutique firm’s technical acumen rivals that of a large firm while delivering responsive, personalized service in a small-office setting.
When we acquired our company, we obtained a client distribution list as part of the deal. WE kept the same delivery driver. After a few months, we realized the driver was consigning with a competitor to distribute our product. We contacted Emmanuel Coffy who informed us that a “client distribution list” may be proprietary information deserving of protection. Mr. Coffy diligently took the proper course of action to protect our client distribution list……..Iverson L.
Emmanuel Coffy drafted my patent application which was quickly issued. Some fie years later when an office action was issued against the another application, I searched for and found Emmanuel to draft the response for me. I was confident he would do the best job……David F.
When we applied for a trademark, a competitor instituted an opposition proceeding against us. We chose CoffyLaw to represent us, because the firm was the most knowledgeable and cost effective among the other firms we consulted……Paul M.
I had an idea I needed to protect. Not knowing where to turn, I was drawn to an organization that was featured through TV advertising. Bought in. After a substantial deposit and retainer totaling more than $10,000 and a long waiting period, I was totally dissatisfied with the results. I was later introduced to Emmanuel Coffy. He expeditiously obtained my design patent for a fraction of the cost. I’m now the proud inventor of a design patent…..Michaela W.
Fritzner L. Altidor, Esq. CPA
US Federal Court Of Appeals For The Federal Circuit
The Korean electronics giant has bought Corephotonics, an Israeli startup that is taking on Apple in Judge Lucy Koh’s Northern District of California courtroom
Large portfolios can often give companies a lot of sway in licensing discussions, but those numbers can be manipulated and skew the true strength of a business’s patent position.
From uncertainty over patent eligibility to the forces of convergence increasingly shaping the sector, IP strategy has never been more important for medical device companies.
Shanghai was the only place to be in early December as IPBC Asia once again attracted the continent’s leading patent players for three days of discussion and debate, along with plenty of networking.
Due to inclement weather, the United States Court of Appeals for the Federal Circuit will operate on a 3-hour delay on Wednesday, January 30, 2019. Unscheduled leave and telecommuting are authorized as approved by supervisors. Chambers staff should f…
Ford faces new confrontation over alleged infringement of MIT-owned IP, but number of suits against car giant well down from 2012-2014 peak
Swedish company issues statement after an unsourced Chinese media article claims that a probe into its licensing practices is underway
SPC disputes, second medical use issues, pharma UPC strategies, CRISPR and much more from IAM’s third annual pharma and biotech IP conference, which took place in London earlier this week
Delaware lawsuit is first move to litigate assets since former RPX dealmaker took control of portfolio
Brand name pharmaceutical companies are facing a policy-making onslaught; with their IP strategies firmly in the spotlight, many are being forced to speak up for the rights that underpin their products.